Seeking Alpha

Mast Therapeutics, Inc. (MSTX)

  • InvestingInsights | Send Message 20h

    $MSTX Roth Capital Weighs In on Mast Therapeutics Inc Ahead of 4th Annual Sickle Cell Disease Conference
      • Bret Jensen | Send Message 26 Aug

        Mast Therapeutics: A High Risk/High Reward Play $MSTX
          • InvestingInsights | Send Message 17 Aug

            $MSTX Cowen Maintains Outperform on Mast Therapeutics Inc Ahead of Sickle Cell Crisis EPIC Data in 1Q:16
              • Ocean Man | Send Message 14 Aug

                $MSTX quietly went up 23% yesterday.
                Reply (4)
              • View all 4 replies
                • Newbie 5 | Send Message 14 Aug
                  : Got in at 0.40...thanks OM!!
                • afterdigital | Send Message 14 Aug
                  : Had followed you in @ 39.5 thanks OM
                  • InvestingInsights | Send Message 13 Aug

                    $MSTX Canaccord Reiterates Buy on Mast Therapeutics Inc Ahead of Top-line Phase 3 Sickle Cell Data
                      • muldoon1959 | Send Message 13 Aug

                        Boom. $MSTX lift-off.
                          • Xvansan | Send Message 5 Aug

                            $ARP now joins $LL $MSTX $TNXP $VRNG $WTSL $LF $SN $CRK $TPLM $BABA $MNKD and many others as horrible stock picks I have seen on SA
                            Reply (17)
                          • View all 17 replies
                            • tromur | Send Message 5 Aug
                              : I think TNXP is good buy at these levels. Sell in 10s. I think floor is offering price of $7.50
                            • jonanne | Send Message 6 Aug
                              : Xvansan-The point I'm making is that this is a long term play, not a trade (although some traders like Ocean Man have done well).
                              • joelkatz | Send Message 4 Aug

                                Bought $MSTX at $0.42
                                  • Ocean Man | Send Message 3 Aug

                                    Added to $MSTX at $0.437.
                                    Reply (5)
                                  • View all 5 replies
                                    • mstar991 | Send Message 3 Aug
                                      : ARP ?
                                    • joelkatz | Send Message 4 Aug
                                      : Follwed at .42
                                      • forever5683 | Send Message 24 Jul

                                        $MSTX $3 price target & insider acquired shares, LONG, 1st QTR 2016 expecting clinical data.
                                          Visit Seeking Alpha's
                                          MSTX vs. ETF Alternatives
                                          Company Description
                                          Mast Therapeutics Inc is a biopharmaceutical company. The Company is engaged in developing novel therapies for serious or life-threatening diseases with unmet needs. Its pipeline includes MST-188 development programs in adjunctive thrombolytic therapy.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States